Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Olfactory Bulb | 1 | 2020 | 333 | 0.65 | Why? |
| Blood | 1 | 2015 | 274 | 0.55 | Why? |
| Blood Culture | 1 | 2015 | 308 | 0.50 | Why? |
| Taiwan | 15 | 2021 | 2556 | 0.45 | Why? |
| Pseudomonas Infections | 1 | 2015 | 425 | 0.42 | Why? |
| Bacteremia | 3 | 2018 | 1372 | 0.42 | Why? |
| Pseudomonas aeruginosa | 1 | 2015 | 652 | 0.41 | Why? |
| Typhus, Endemic Flea-Borne | 2 | 2017 | 25 | 0.30 | Why? |
| Pneumonia, Pneumocystis | 2 | 2017 | 322 | 0.24 | Why? |
| Macau | 1 | 2020 | 116 | 0.21 | Why? |
| Pneumocystis carinii | 2 | 2017 | 205 | 0.18 | Why? |
| Scrub Typhus | 1 | 2017 | 68 | 0.16 | Why? |
| Quarantine | 2 | 2021 | 18418 | 0.16 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2017 | 170 | 0.16 | Why? |
| Photosensitizing Agents | 1 | 2018 | 279 | 0.15 | Why? |
| Q Fever | 1 | 2017 | 130 | 0.15 | Why? |
| Legionella pneumophila | 1 | 2016 | 143 | 0.15 | Why? |
| Legionnaires' Disease | 1 | 2016 | 108 | 0.15 | Why? |
| Prothrombin Time | 1 | 2017 | 434 | 0.15 | Why? |
| Luminescent Measurements | 1 | 2020 | 924 | 0.15 | Why? |
| Everolimus | 1 | 2017 | 215 | 0.14 | Why? |
| Severe Dengue | 1 | 2017 | 135 | 0.14 | Why? |
| Catechin | 1 | 2018 | 244 | 0.14 | Why? |
| Acinetobacter baumannii | 1 | 2018 | 378 | 0.14 | Why? |
| AIDS-Related Opportunistic Infections | 1 | 2017 | 260 | 0.14 | Why? |
| Drug Resistance, Neoplasm | 1 | 2018 | 447 | 0.14 | Why? |
| Community-Acquired Infections | 2 | 2016 | 2328 | 0.13 | Why? |
| Case Management | 1 | 2015 | 285 | 0.12 | Why? |
| Vancomycin Resistance | 1 | 2012 | 55 | 0.12 | Why? |
| Enterococcus | 1 | 2012 | 73 | 0.12 | Why? |
| Thorax | 1 | 2020 | 1873 | 0.10 | Why? |
| Tertiary Care Centers | 3 | 2016 | 8248 | 0.10 | Why? |
| Clostridium Infections | 1 | 2016 | 595 | 0.10 | Why? |
| Gram-Positive Bacterial Infections | 1 | 2012 | 323 | 0.09 | Why? |
| Anti-Bacterial Agents | 4 | 2018 | 10083 | 0.09 | Why? |
| Anti-HIV Agents | 2 | 2017 | 2209 | 0.08 | Why? |
| Heart Transplantation | 1 | 2017 | 1293 | 0.08 | Why? |
| Dengue | 1 | 2018 | 1565 | 0.08 | Why? |
| Artificial Intelligence | 1 | 2020 | 3543 | 0.07 | Why? |
| Immunoassay | 1 | 2020 | 4485 | 0.07 | Why? |
| Continuity of Patient Care | 1 | 2015 | 1574 | 0.07 | Why? |
| Patient Discharge | 1 | 2020 | 5696 | 0.07 | Why? |
| Retrospective Studies | 8 | 2021 | 105322 | 0.07 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.07 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.06 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.06 | Why? |
| Magnetic Resonance Imaging | 1 | 2020 | 6551 | 0.06 | Why? |
| Adenosine Monophosphate | 1 | 2020 | 5652 | 0.06 | Why? |
| Alanine | 1 | 2020 | 5687 | 0.06 | Why? |
| Aged | 11 | 2021 | 215776 | 0.06 | Why? |
| Young Adult | 5 | 2020 | 93724 | 0.05 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.05 | Why? |
| CD4 Lymphocyte Count | 2 | 2017 | 1517 | 0.05 | Why? |
| Middle Aged | 12 | 2020 | 270681 | 0.05 | Why? |
| Immunocompromised Host | 1 | 2017 | 5150 | 0.05 | Why? |
| Health Policy | 1 | 2020 | 6242 | 0.05 | Why? |
| Humans | 20 | 2021 | 930598 | 0.05 | Why? |
| Male | 14 | 2021 | 367725 | 0.05 | Why? |
| Female | 14 | 2021 | 380317 | 0.05 | Why? |
| Microbial Sensitivity Tests | 2 | 2018 | 2886 | 0.05 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.05 | Why? |
| Streptococcus | 1 | 2018 | 76 | 0.05 | Why? |
| DNA-Directed RNA Polymerases | 1 | 2020 | 239 | 0.05 | Why? |
| Immunosuppressive Agents | 1 | 2017 | 6331 | 0.05 | Why? |
| Antiviral Agents | 3 | 2020 | 41703 | 0.05 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.05 | Why? |
| Dihydropteroate Synthase | 1 | 2017 | 8 | 0.05 | Why? |
| Levofloxacin | 1 | 2018 | 115 | 0.04 | Why? |
| Bacterial Proteins | 2 | 2017 | 1318 | 0.04 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.04 | Why? |
| Masks | 1 | 2020 | 8528 | 0.04 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.04 | Why? |
| Cross Infection | 2 | 2016 | 8675 | 0.04 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.04 | Why? |
| Hospitals, Isolation | 1 | 2020 | 300 | 0.04 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.04 | Why? |
| Aged, 80 and over | 6 | 2018 | 88759 | 0.04 | Why? |
| Calcineurin Inhibitors | 1 | 2017 | 218 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| Bacterial Toxins | 1 | 2016 | 185 | 0.04 | Why? |
| Prognosis | 2 | 2017 | 32490 | 0.04 | Why? |
| Partial Thromboplastin Time | 1 | 2017 | 436 | 0.04 | Why? |
| Carbapenems | 1 | 2018 | 343 | 0.04 | Why? |
| Escherichia coli Infections | 1 | 2018 | 348 | 0.04 | Why? |
| Adult | 9 | 2020 | 244371 | 0.04 | Why? |
| Enterobacteriaceae | 1 | 2018 | 395 | 0.04 | Why? |
| Microbial Viability | 1 | 2018 | 406 | 0.03 | Why? |
| Candidemia | 1 | 2018 | 353 | 0.03 | Why? |
| Tacrolimus | 1 | 2017 | 435 | 0.03 | Why? |
| Urine | 1 | 2016 | 469 | 0.03 | Why? |
| Molecular Structure | 1 | 2018 | 1539 | 0.03 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.03 | Why? |
| Enterobacteriaceae Infections | 1 | 2018 | 529 | 0.03 | Why? |
| Oxazolidinones | 1 | 2012 | 49 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.03 | Why? |
| Ascorbic Acid | 1 | 2018 | 676 | 0.03 | Why? |
| Proportional Hazards Models | 2 | 2017 | 6543 | 0.03 | Why? |
| Time Factors | 1 | 2015 | 31397 | 0.03 | Why? |
| Daptomycin | 1 | 2012 | 64 | 0.03 | Why? |
| Antiretroviral Therapy, Highly Active | 1 | 2017 | 952 | 0.03 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.03 | Why? |
| Linezolid | 1 | 2012 | 160 | 0.03 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.03 | Why? |
| Acetamides | 1 | 2012 | 141 | 0.03 | Why? |
| Mortality | 2 | 2018 | 7132 | 0.03 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.03 | Why? |
| Aspartate Aminotransferases | 1 | 2017 | 1394 | 0.02 | Why? |
| Bilirubin | 1 | 2012 | 503 | 0.02 | Why? |
| Cross Reactions | 1 | 2020 | 4374 | 0.02 | Why? |
| Vancomycin | 1 | 2012 | 328 | 0.02 | Why? |
| Staphylococcal Infections | 1 | 2018 | 1099 | 0.02 | Why? |
| HIV Infections | 1 | 2015 | 11620 | 0.02 | Why? |
| Analysis of Variance | 1 | 2012 | 950 | 0.02 | Why? |
| Drug Resistance, Bacterial | 1 | 2017 | 1414 | 0.02 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.02 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.02 | Why? |
| Universities | 1 | 2021 | 4374 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.02 | Why? |
| Diarrhea | 1 | 2016 | 2743 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.02 | Why? |
| Incidence | 2 | 2017 | 25622 | 0.02 | Why? |
| HIV-1 | 1 | 2017 | 3365 | 0.01 | Why? |
| Caregivers | 1 | 2016 | 3112 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.01 | Why? |
| Hospitals, University | 1 | 2012 | 4173 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2015 | 9893 | 0.01 | Why? |
| Hospitals | 1 | 2018 | 11793 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.01 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.01 | Why? |
| Animals | 2 | 2020 | 78931 | 0.01 | Why? |
| Pneumonia | 1 | 2016 | 5652 | 0.01 | Why? |
| Hospitalization | 2 | 2017 | 54280 | 0.01 | Why? |
| Child | 2 | 2017 | 70012 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.01 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Mice | 1 | 2012 | 21357 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Intensive Care Units | 1 | 2017 | 29594 | 0.01 | Why? |
| Prospective Studies | 1 | 2015 | 43301 | 0.01 | Why? |
Lee's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(143)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(54)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_